Table 1.

Summary of the participants in this study.

Phase	Group	Gestational weeks (week)	n	Platform
Cohort study	Pregnant women with GDM	8–41	106	–
	Healthy pregnant women	8–41	630
Discovery	Pregnant women with GDM	15–24	6	Microarray
	Healthy pregnant women	15–24	6
Training	GDM	15–24	12	qRT-PCR
	Control	15–24	12
Test	GDM	15–24	18	qRT-PCR
	Control	15–24	18